immuno-oncology
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
September, 2024
September 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« Aug
immuno-oncology
Sep 2, 2024, 08:40 |
Blog
David Braun: We can make a personalized vaccine to target those tumor-specific antigens
Dana-Farber Cancer Institute shared a post on X: “'If we can identify neoantigens specific to…
Aug 25, 2024, 12:48 |
Blog
The development of multimodal AI for clinical decision making in immunotherapy - NCI Systems Biology
NCI Systems Biology shared a post on X: "On Aug. 29 at 2:30 pm ET, Anant…
Aug 10, 2024, 19:12 |
Societies
Register for the SITC Immuno-oncology Drug Development Summit in Boston
Society for Immunotherapy of Cancer (SITC) shared on X: "Register for the SITC Immuno-oncology Drug…
Aug 5, 2024, 15:54 |
Career
Shivan Sivakumar: I am celebrating being at University of Birmingham for a year
Shivan Sivakumar, Associate Professor in oncology at the University of Birmingham, shared on X: "This…
Aug 3, 2024, 03:01 |
Blog
Belén Garijo on Q2 results from Merck
Belén Garijo shared a post on LinkedIn: "We published our Q2 results today! Earlier this…
Jul 31, 2024, 09:17 |
Blog
New Lung Cancer Considered episode, the use of ICIs in the treatment of molecular driven NSCLC
IASLC shared on X: "In this Lung Cancer Considered episode, Narjust Florez and 2 esteemed…
Jul 28, 2024, 08:50 |
Insight
Novartis collaborates with Dren Bio to discover and advance novel antibody-based immune cell engagers
Fiona Hamilton Marshall, President of the Novartis Institute for BioMedical Research, shared on LinkedIn: “I’m…
Jul 26, 2024, 14:16 |
Blog
2024 Multi-omics Meeting in Australia - Society for Immunotherapy of Cancer
Society for Immunotherapy of Cancer (SITC) shared a post on X: "Connect with global researchers…
Jul 19, 2024, 14:44 |
Blog
"What’s Next for Immunotherapies?" by Anas Younes
Anas Younes shared a post on LinkedIn: Immunotherapies Immunotherapies "My interview with Mark Cobbold, Senior…
Jul 19, 2024, 02:00 |
Blog
I ask Agenus to consider Armenia as the first country to register the BOT/BAL combination: Gevorg Tamamyan
"~20% ORR and 90% alive at 6 months in comparison to ZERO! How many patients…
Jul 18, 2024, 15:20 |
Drugs
Our commitment to seek all possible pathways to make BOT/BAL available to patients is unwavering: Steven O'Day, Agenus CMO
Agenus shared on LinkedIn: "Today, we announced the outcomes of our End-of-Phase 2 meeting and…
Jul 14, 2024, 21:15 |
Blog
Sumanta K. Pal: Excellent use of Twitter polls to reconcile tough clinical scenarios
Sumanta K. Pal shared a post on X: ''Brilliant insights from Tom Powles, Barts Cancer Institute.…
Jul 14, 2024, 07:19 |
Insight
Immuno-oncologic profiling of pediatric brain - Hawkins Lab
Hawkins Lab shared a recent paper on X, titled "Immuno-oncologic profiling of pediatric brain tumors reveals…
Jul 10, 2024, 05:18 |
Insight
APEIRON Biologics to be Acquired by Ligand Pharmaceuticals for USD 100 Million
APEIRON Biologics AG (“APEIRON”), a leading Austrian biotech company, today announced that its shareholders have…
Jul 7, 2024, 17:43 |
Insight
Jarushka Naidoo: ctDNA+ associates with outcomes in stage III unresectable NSCLC
Jarushka Naidoo shared a post on X: “ctDNA+ in consolidation IO trial (BTCRC 16-081) associates…
Jun 27, 2024, 12:44 |
Societies
Discuss the future of immuno-oncology with Agenus at ESMOGI24
Agenus shared on LinkedIn: "If you are a physician attending ESMOGI24 in Munich from June…
Jun 27, 2024, 09:10 |
Insight
The promise of immuno-oncology in the neoadjuvant setting - ESMO
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “The promise of immuno-oncology in…
Jun 18, 2024, 23:25 |
Insight
The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn: “Are you a physician attending ESMO GI 24? Join…
Jun 11, 2024, 15:17 |
Blog
Julian Ashby: Deep preclinical characterization is essential to increase the chances of success in clinical trials
Julian Ashby, Product Marketing Manager at LUMICKS, shared on LinkedIn: “Each year, companies use tens…
Jun 4, 2024, 05:09 |
Insight
Join us in Chicago to discuss the future of immuno-oncology - Agenus
Agenus shared a post on LinkedIn: “Are you a physician attending ASCO24? Join us in…
May 1, 2024, 13:27 |
Blog
Jennifer Marks: Reconsideration of IO in the inpatient setting
Jennifer Marks, Hematologist, Oncologist at MedStar Georgetown University Hospital, shared on X/Twitter: "Poster presentation on reconsideration…
Apr 23, 2024, 23:33 |
Insight
Narjust Florez: Jessica Donington dissects adjuvant Immuno-Oncology in lung cancer
Narjust Florez shared a post on X: “Jessica Donington dissects adjuvant Immuno-Oncology in lung cancer.…
Apr 22, 2024, 10:32 |
Blog
Narjust Florez: Dr. Julia Rotow discussed the role of IO in patients with target mutations
Narjust Florez shared a post on X: "IO and target therapy? Dr. Julia Rotow discussed…
Apr 19, 2024, 05:17 |
Insight
Dina Schneider: Excited about our recent publication on Armored TGFBRIIdn ROR1-targeting CAR T cells for solid tumors
Dina Schneider, Director of Immuno Oncology and Cell Therapy at Lentigen Technology, shared on LinkedIn:…
Apr 4, 2024, 14:40 |
Career
Nick Slack: I'm excited and humbled to announce my new role as Chairman and CEO of The START Center for Cancer Research
Nick Slack, Chairman and CEO of The START Centre for Cancer Research, shared on LinkedIn:…
Mar 28, 2024, 03:20 |
Blog
Roberto Iacovelli: Thrilled to announce that TIDE-A trial is finally out on European Urology
Roberto Iacovelli, Associate Professor of Medical Oncology at Sacro Cuore Catholic University of Rome, shared on…
Mar 24, 2024, 13:47 |
Career
Jean-Charles Soria: Thank you to my American Association for Cancer Research colleagues for this humbling vote of confidence
Jean-Charles Soria, SVP and Oncology Therapeutic Area Head, shared Amgen Oncology's post on LinkedIn and…
Jan 18, 2024, 15:12 |
Blog
Maria Natalia Gandur Quiroga: Immuno-Oncology Advances in Genitourinary Cancers
Maria Natalia Gandur Quiroga shared a post on LinkedIn: "Immuno-Oncology Advances in Genitourinary Cancers: Introduction:…
Jan 9, 2024, 09:37 |
Blog
“The Immuno-Oncology Curve” with Dr. Steven O’Day – Guests are Alexa Morell, Marianne Pearson and Andrew Wortmann
Steven O’Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "Happy New Year! I’m…
Dec 18, 2023, 21:17 |
Insight
Anthony Zamora: How advancements in sequencing technologies and bioinformatics pipelines have advanced our ability to identify cancer neoantigens
Anthony Zamora, Assistant Professor at the Medical College of Wisconsin, announced on LinkedIn: "Happy to…
Nov 28, 2023, 16:14 |
Blog
“The Immuno-Oncology Curve" with Dr. Steven O'Day - Guest is Alexander (Lex) Eggermont
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "I’m excited to announce…
Nov 20, 2023, 10:30 |
Insight
Steven O'Day: I am thrilled to announce the upcoming launch of “The Immuno-Oncology Curve”
Steven O'Day, the Chief Medical Officer of Agenus, shared on LinkedIn: "I am thrilled to…
Nov 17, 2023, 16:24 |
Drugs
Caroline J Loew: We’re excited to launch Mural Oncology
Caroline J Loew, CEO of Mural Oncology, shared Mural Oncology's post on LinkedIn adding: "We’re…
Nov 17, 2023, 13:59 |
Insight
Revolutionizing Cancer Immunotherapy: Next-Gen CTLA-4 Targeting and Combination Therapies
Dive into the groundbreaking research published in "Oncology Immunology" (2023), where leading scientists Nils-Petter Rudqvist,…
Sep 24, 2023, 18:03 |
Blog
Pashtoon Murtaza Kasi: The imagery at RareCyte Incorporated will blow your mind.
Quoting Pashtoon Murtaza Kasi, Oncologist and Researcher at Weill Cornel Medicine and New York- Presbyterian…
Sep 22, 2023, 17:54 |
Blog
Together, we're shaping the future of healthcare! - IMAGIO Project
Quoting IMAGIO Project on LinkedIn: "The IMAGIO Consortium is composed by top experts in the…
Sep 12, 2023, 18:48 |
Blog
Eric Deutsch: The countdown begins as ImmunoRad2023 7th edition fast approaches.
Quoting Eric Deutsch, Head of the Gustave Roussy Radiotherapy Department, on LinkedIn: ''The countdown begins as…
Aug 22, 2023, 18:09 |
Career
Beatrice Duvert: I’m happy to share that I’m starting a new position as an Associate Program Manager at Agenus!
Quoting Beatrice Duvert, Associate Program Manager at Agenus, on LinkedIn: "I’m happy to share that…
All:
38
Posts:
1 - 100
OncoDaily Announces Strategic Partnership with the Asian Fund for Cancer Research Limited (AFCR)
Peyo the Therapy Horse: Comforting Terminally Ill Patients Through Horse Therapy.
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 3
Small Bowel Cancer: Symptoms & Causes, Types, Diagnosis and Treatment
Mikkael A. Sekeres, Candidate for Secretary of ASH
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube